StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.51−0.02 (-1.31%)

Close on Nov 18, 2026Market cap $1.98MP/E –Yield –

Can-Fite BioPharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$9.95M. The highest annual figure on record is -$5.41M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.95M–
FY2024Dec 31, 2024-$8.13M–
FY2023Dec 31, 2023-$8.20M–
FY2022Dec 31, 2022-$10.10M–
FY2021Dec 31, 2021-$12.84M–
FY2020Dec 31, 2020-$14.14M–
FY2019Dec 31, 2019-$12.01M–
FY2018Dec 31, 2018-$5.41M–
FY2017Dec 31, 2017-$7.19M–
FY2016Dec 31, 2016-$8.68M–
FY2015Dec 31, 2015-$6.48M–

More Can-Fite BioPharma figures

See a number that looks wrong?